688 results on '"El-Chami, Mikhael F."'
Search Results
152. Diagnosis and management of subcutaneous implantable cardioverter‐defibrillator infections based on process mapping
153. Cardiac implantable electronic devices in patients with persistent left superior vena cava—A single center experience
154. Outcomes of convergent atrial fibrillation ablation with continuous rhythm monitoring
155. Reduced bacterial adhesion with parylene coating: Potential implications for Micra transcatheter pacemakers
156. Using Medicare Claims to Identify Acute Clinical Events Following Implantation of Leadless Pacemakers
157. Comparison of echocardiographic and fluoroscopic sizing of the left atrial appendage prior to percutaneous closure
158. Pseudo-Ventricular Over and Under-Sensing during an Episode of Double Tachycardia. What is the Mechanism?
159. A Diagnostic Response of a Supraventricular Tachycardia to a Ventricular Premature Beat
160. Pacing Features That Mimic Malfunction: A Review of Current Programmable and Automated Device Functions That Cause Confusion in the Clinical Setting
161. Sealing the Left Atrial Appendage: Ready for Prime Time?
162. Clinical Outcomes Three Years After Plaato Implantation
163. The Use of Echocardiography for the Evaluation of Dyssynchrony
164. Effect of Lipid Levels and Lipid-Lowering Therapy on Restenosis after Coronary Artery Stenting
165. Atrial Septal Abnormalities and Cryptogenic Stroke: A Paradoxical Science
166. Prospective evaluation of health status, quality of life and clinical outcomes following implantable defibrillator generator exchange.
167. Femoral extraction of transvenous leads and leadless pacemakers—A review of the data, tools, and procedural steps
168. Extraction of a 4-year-old leadless pacemaker with a tine-based fixation
169. Response to the Letter to the Editor “Selection of Appropriate Patients for Figure‐of‐Eight Suturing During Removal of Large Bore Transfemoral Sheaths”
170. Incidence and outcomes of systemic infections in patients with leadless pacemakers: Data from the Micra IDE study
171. The Safety and Feasibility of Same-Day Discharge After Implantation of MICRA Transcatheter Leadless Pacemaker System
172. Outcomes of percutaneous vacuum‐assisted debulking of large vegetations as an adjunct to lead extraction
173. Outcomes of Micra leadless pacemaker implantation with uninterrupted anticoagulation
174. Leadless pacemaker implant in patients with pre‐existing infections: Results from the Micra postapproval registry
175. Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control
176. Abstract 16812: Clinical Use of Rate Adaptive Pacing With a Leadless Pacemaker: Results From the Micra Transcatheter Pacing System Post-Approval Registry
177. Incidence of Cancer Treatment–Induced Arrhythmia Associated With Novel Targeted Chemotherapeutic Agents
178. Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke.
179. Atrio‐ventricular synchronous pacing with a single chamber leadless pacemaker: Programming and trouble shooting for common clinical scenarios.
180. Life cycle management of Micra transcatheter pacing system: Data from a high‐volume center.
181. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial.
182. Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker.
183. Intermediate-term mortality and incidence of ICD therapy in octogenarians after cardiac resynchronization therapy
184. A Predictive Model for the Long-Term Electrical Performance of a Leadless Transcatheter Pacemaker
185. Rising burden of cardiac arrest– and heart failure–related mortality in the United States from 1999 to 2020
186. Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study.
187. Leadless pacemakers reduce risk of device-related infection: Review of the potential mechanisms.
188. Comparison of echocardiographic and fluoroscopic sizing of the left atrial appendage prior to percutaneous closure.
189. Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative results.
190. Patient selection, pacing indications, and subsequent outcomes with de novo leadless single-chamber VVI pacing.
191. Implantable Cardioverter-Defibrillator Placement for Primary Prevention in 2,346 Patients: Predictors of One-Year Survival
192. Effect of defibrillation threshold testing on effectiveness of the subcutaneous implantable cardioverter defibrillator
193. Magnetic resonance imaging safety in nonconditional pacemaker and defibrillator recipients: A meta-analysis and systematic review
194. Procedural outcomes and long-term survival associated with lead extraction in patients with abandoned leads
195. Leadless pacemaker implantation and concurrent atrioventricular junction ablation in patients with atrial fibrillation
196. Subcutaneous implantable cardioverter-defibrillator implantation in a patient with bilateral pectoral deep brain stimulators
197. Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results
198. Long-term survival of implantable cardioverter defibrillator recipients with end-stage renal disease
199. CI-452769-2 PERFORMANCE OF LEADLESS PACEMAKERS IN EXTENDED FOLLOW-UP: 5 YEAR RESULTS FROM THE MICRA VR TRANSCATHETER PACING SYSTEM POST-APPROVAL REGISTRY.
200. PO-05-025 LONGER TERM OUTCOMES IN PATIENTS PRECLUDED FOR TRANSVENOUS PACEMAKER IMPLANTATION: EXPERIENCE WITH THE MICRA VR TRANSCATHETER PACEMAKER.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.